Plug Power to Announce 2016 Third Quarter Results on November 7, 2016
Oct 27, 2016 11:03 am UTC| Business
LATHAM, N.Y., Oct. 27, 2016 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing energy solutions that change the way the world moves, today confirms it will release the Company’s 2016 third quarter results on...
LKQ Corporation Announces Third Quarter 2016 Financial Results
Oct 27, 2016 11:03 am UTC| Business
Revenue growth of 30.3% to $2.4 billionOrganic revenue growth for parts and services of 3.7%Net income growth of 21.1%; adjusted net income growth of 26.8%Diluted EPS of $0.40; adjusted diluted EPS of $0.45Annual guidance...
DuPont Fabros Technology, Inc. Reports Third Quarter 2016 Results
Oct 27, 2016 11:02 am UTC| Business
Record leasing of 48.05 megawatts of critical load year to dateDouble digit Revenue, EPS, Normalized FFO per share and AFFO per share growth WASHINGTON, Oct. 27, 2016 -- DuPont Fabros Technology, Inc. (NYSE:DFT)...
DuPont Fabros Technology, Inc. Reports Third Quarter 2016 Results
Oct 27, 2016 11:02 am UTC| Business
Record leasing of 48.05 megawatts of critical load year to dateDouble digit Revenue, EPS, Normalized FFO per share and AFFO per share growth WASHINGTON, Oct. 27, 2016 -- DuPont Fabros Technology, Inc. (NYSE:DFT)...
The Bon-Ton Stores, Inc. Announces January Closing of Its Hamden Bon-Ton Store
Oct 27, 2016 11:02 am UTC| Business
MILWAUKEE, Wis., Oct. 27, 2016 -- The Bon-Ton Stores, Inc. (NASDAQ:BONT), today announced it will close its Bon-Ton store at the Hamden Mart in Hamden, Connecticut. The Company will not renew the lease, which terminates...
Sandy Spring Bancorp Increases Quarterly Dividend to $0.26 Per Share
Oct 27, 2016 11:02 am UTC| Business
OLNEY, Md., Oct. 27, 2016 -- Sandy Spring Bancorp, Inc., (Nasdaq:SASR), the parent company of Sandy Spring Bank, announced that the board of directors declared a quarterly common stock dividend of $0.26 per share...
Opiant Pharmaceuticals, Inc. Announces FDA Orange Book Listing for Narcan® Nasal Spray Patent
Oct 27, 2016 11:01 am UTC| Business
SANTA MONICA, Calif., Oct. 27, 2016 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders,...